Published in Clin Pharmacol Ther on June 19, 1973
Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1974) 2.08
Comparative nephrotoxicity of gentamicin and tobramycin in rats. Antimicrob Agents Chemother (1978) 1.69
Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin. Antimicrob Agents Chemother (1975) 1.56
Accumulation pharmacokinetics of tobramycin. Antimicrob Agents Chemother (1978) 1.51
Renal extraction of gentamicin in anesthetized dogs. Antimicrob Agents Chemother (1976) 1.45
Renal pharmacology of netilmicin. Antimicrob Agents Chemother (1977) 1.29
[Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin]. Antimicrob Agents Chemother (1975) 1.26
Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin. Br Med J (1974) 1.24
Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. Br J Clin Pharmacol (2004) 1.21
Feasibility of administering aminoglycoside antibiotics by continuous intravenous infusion. Antimicrob Agents Chemother (1975) 1.20
Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis, and patients on chronic hemodialysis. Antimicrob Agents Chemother (1974) 1.05
Comparison of netilmicin and gentamicin pharmacokinetics in humans. Antimicrob Agents Chemother (1980) 1.03
Pharmacokinetic parameters of sisomicin. Antimicrob Agents Chemother (1976) 1.03
Gentamicin and gentamicin C1 in the treatment of complicated urinary tract infections: comparative study of efficacy, tolerance, and pharmacokinetics. Antimicrob Agents Chemother (1975) 1.01
Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteers. Antimicrob Agents Chemother (1987) 0.96
Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species. Can Med Assoc J (1975) 0.96
Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary disease. Antimicrob Agents Chemother (1979) 0.95
Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. Antimicrob Agents Chemother (1985) 0.95
Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis. Antimicrob Agents Chemother (1978) 0.92
Comparison of the distribution of tobramycin and gentamicin in body fluids of dogs. Antimicrob Agents Chemother (1974) 0.92
Pharmacokinetic studies with dibekacin, a new aminoglycoside, after intravenous and intramuscular administration to human volunteers. Antimicrob Agents Chemother (1980) 0.85
Predicted tissue accumulation of netilmicin in patients. Antimicrob Agents Chemother (1981) 0.84
Evaluation of three antibiotic programs in newborn infants. Can Med Assoc J (1978) 0.83
Pharmacokinetics of intravenously administered isepamicin in men. Antimicrob Agents Chemother (1995) 0.81
Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administration. Antimicrob Agents Chemother (1995) 0.81
Influence of hydrocortisone on gentamicin-induced nephrotoxicity in rats. Antimicrob Agents Chemother (1988) 0.80
Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms. Can Med Assoc J (1977) 0.80
Evaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin. Br J Clin Pharmacol (1987) 0.75
Antibiotic blood concentrations in patients successfully treated with tobramycin. Postgrad Med J (1981) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol (1966) 27.11
EXTRACTION OF A HIGHLY POTENT PENICILLIN INACTIVATOR FROM PENICILLIN RESISTANT STAPHYLOCOCCI. Science (1944) 12.53
Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr (1973) 6.29
Antibiotic synergism of enterococci. Relation to inhibitory concentrations. Arch Intern Med (1970) 5.73
GROUP A HEMOLYTIC STREPTOCOCCUS ANTIBODIES. I. GRIFFITH TYPE AGGLUTININ AND ANTISTREPTOLYSIN TITERS IN NORMAL MEN AND IN ACUTE INFECTIONS. J Clin Invest (1943) 4.30
Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis (1973) 3.91
Inactivation of cephalothin and cephaloridine by Staphylococcus aureus. J Bacteriol (1965) 2.94
Serum protein binding of the aminoglycoside antibiotics. Antimicrob Agents Chemother (1972) 2.79
THE ABSORPTION AND EXCRETION OF PENICILLIN FOLLOWING CONTINUOUS INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION. J Clin Invest (1944) 2.74
THE TREATMENT OF SUBACUTE BACTERIAL ENDOCARDITIS WITH PENICILLIN. J Clin Invest (1945) 2.65
Synergism of carbenicillin and gentamicin against enterococci. Antimicrob Agents Chemother (1973) 2.60
Clinical pharmacology of cefamandole as compared with cephalothin. Antimicrob Agents Chemother (1976) 2.58
Gentamicin: in vitro studies. J Infect Dis (1969) 2.46
Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob Agents Chemother (1972) 2.35
Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group. Clin Infect Dis (1998) 2.19
Laboratory and pharmacologic studies of BL-P-1322 (cephapirin sodium) in children. Curr Ther Res Clin Exp (1971) 2.17
Comparative pharmacokinetics of amikacin and kanamycin. Clin Pharmacol Ther (1974) 2.15
Disseminated infection due to Actinomyces meyeri: case report and review. Clin Infect Dis (1996) 2.04
Relative inactivation by Staphylococcus aureus of eight cephalosporin antibiotics. Antimicrob Agents Chemother (1976) 1.98
Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus. J Infect Dis (1975) 1.94
Bioassay of metronidazole with either anaerobic or aerobic incubation. J Infect Dis (1975) 1.86
Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients. Postgrad Med J (1971) 1.81
A rapid, modified ultrafiltration method for determining serum protein binding and its application to new penicillins. J Lab Clin Med (1965) 1.80
Laboratory and clinical experience with cephalexin. Antimicrob Agents Chemother (Bethesda) (1968) 1.76
Clinical pharmacology of carbenicillin compared with other penicillins. J Infect Dis (1970) 1.68
Granular cell tumor of the biliary tree. A report of two cases and a review of the literature. Am J Surg Pathol (1991) 1.61
Fecal indicator bacteria persistence under natural conditions in an ice-covered river. Appl Environ Microbiol (1976) 1.56
Influence of several antibiotics, singly and in combination, on the growth of Listeria monocytogenes. J Pediatr (1972) 1.50
Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int (1976) 1.48
Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens. Antimicrob Agents Chemother (1975) 1.43
Life-threatening complications of hepatitis B virus-related polyarteritis nodosa developing despite interferon-alpha2b therapy: successful treatment with a combination of interferon, lamivudine, plasma exchanges and steroids. Clin Rheumatol (2001) 1.42
Comparative blood levels of hetacillin, ampicillin and penicillin G. N Engl J Med (1966) 1.41
Synergism of penicillin and gentamicin against Listeria monocytogenes in ex vivo hemodialysis culture. J Infect Dis (1977) 1.39
Ticarcillin vs carbenicillin: clinical pharmacokinetics. Clin Pharmacol Ther (1975) 1.37
Comparison of in vitro activity and clinical pharmacology of doxycycline with other tetracyclines. Antimicrob Agents Chemother (Bethesda) (1966) 1.33
Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin. Infection (1974) 1.28
Laboratory and clinical studies of carbenicillin against gram-negative bacilli. Antimicrob Agents Chemother (Bethesda) (1968) 1.27
Pharmacokinetics of cephanone in healthy adult volunteers. Antimicrob Agents Chemother (1973) 1.27
In vitro susceptibility of Haemophilus influenzae to eight antibiotics. Antimicrob Agents Chemother (1974) 1.27
Clinical pharmacology of amikacin and kanamycin. J Infect Dis (1976) 1.26
Inhibitory effect of heparin on gentamicin concentrations in blood. Antimicrob Agents Chemother (1972) 1.24
Mechanisms responsible for the blood level differences of isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin. Arch Intern Med (1968) 1.23
Ampicillin treatment of listeriosis. J Pediatr (1970) 1.23
Serum protein binding of erythromycin, lincomycin, and clindamycin. J Pharm Sci (1973) 1.23
Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration. Antimicrob Agents Chemother (Bethesda) (1966) 1.22
Pharmacokinetics of metronidazole as determined by bioassay. Antimicrob Agents Chemother (1974) 1.21
Antimicrobial resistance of Shigellae isolated in Michigan. JAMA (1975) 1.21
Clinical pharmacology of ampicillin and hetacillin. Ann N Y Acad Sci (1967) 1.19
Mechanisms responsible for plasma levels of nafcillin lower than those of oxacillin. Arch Intern Med (1970) 1.17
Development of staphylococci cross-resistant to cephalexin and methicillin. Antimicrob Agents Chemother (Bethesda) (1968) 1.13
Recurrent peripheral osteoma of mandible: report of case. J Oral Surg (1971) 1.12
Clinical pharmacology of pivampicillin as compared with ampicillin. Antimicrob Agents Chemother (Bethesda) (1970) 1.11
Evaluation of gentamicin and penicillin as a synergistic combination in experimental murine listeriosis. Antimicrob Agents Chemother (1979) 1.09
Theory and applications of pulse dosing: a summary of the symposium. Rev Infect Dis (1981) 1.07
Inactivation of penicillins by the isolated rat liver. J Lab Clin Med (1968) 1.07
In vitro susceptibility of Corynebacterium diphtheriae to thirteen antibiotics. Appl Microbiol (1971) 1.04
Antibiotic susceptibility testing by a standardized single disk method. Tech Bull Regist Med Technol (1966) 1.03
Vancomycin therapy in severe staphylococcal infections. Rev Infect Dis (1982) 1.03
MG++ phospholipids in cell envelopes of a marine and a terrestrial pseudomonad. Biochem Biophys Res Commun (1966) 1.03
Antibiotic synergism against enterococci. J Infect Dis (1970) 1.03
Puerperal fever with Haemophilus vaginalis septicemia. JAMA (1973) 1.01
Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology. Arch Intern Med (1974) 1.01
Vancomycin therapy of severe staphylococcal infections. J Antimicrob Chemother (1984) 0.99
Round table: are new antibiotics needed? Antimicrob Agents Chemother (Bethesda) (1965) 0.99
Pharmacokinetics of fosfomycin. Chemotherapy (1977) 0.97
Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat. Cell Immunol (1985) 0.97
Clinical pharmacology and in vitro activity of phosphonomycin. Antimicrob Agents Chemother (Bethesda) (1969) 0.97
Pharmacokinetics of cephalexin in renal insufficiency. Postgrad Med J (1971) 0.92
Laboratory and clinical comparison of cephaloridine and cephalothin. Antimicrob Agents Chemother (Bethesda) (1965) 0.92
Hemophilus parainfluenzae meningitis. Clin Pediatr (Phila) (1974) 0.89
The pharmacology of orally administered amoxicillin and ampicillin. J Infect Dis (1974) 0.89
Factors Determining the Dosage of Penicillin in the Treatment of Infections. Bull N Y Acad Med (1945) 0.88
Carbenicillin in treatment of severe infections due to pseudomonas. J Infect Dis (1970) 0.88
Efficiency of skin sterilization for a venipuncture with the use of commercially available alcohol or iodine pads. Am J Infect Control (1990) 0.88
Disseminated histoplasmosis and AIDS in Switzerland. Lancet (1986) 0.87
Lack of clinical usefulness of a positive latex agglutination test for Neisseria meningitidis/Escherichia coli antigens in the urine. Pediatr Infect Dis J (1993) 0.87
Disseminated osteomyelitis due to "Battey" mycobacteria. Am Rev Respir Dis (1966) 0.87
Therapeutic aspects of staphylococcal disease. Ann N Y Acad Sci (1965) 0.86
Pseudotumor cerebri in congenital adrenal hyperplasia. Am J Dis Child (1967) 0.85
Zinc metabolism: basic, clinical, and behavioral aspects. J Pediatr (1981) 0.85
The hyperreactive malarial splenomegaly syndrome in a European: has the treatment a modulatory effect on the immune system? J Infect Dis (1990) 0.85
An evaluation of the experimental and investigational status and clinical validity of manipulation of patients under anesthesia: a contemporary opinion. J Manipulative Physiol Ther (2001) 0.85
Pasteurella multocida pneumonia with empyema. Scand J Infect Dis (1998) 0.85
Outbreak of echovirus 30 meningitis in Switzerland. Scand J Infect Dis (1999) 0.84